Monarch Medical Technologies, based in Charlotte, NC, is a leading provider of precision insulin dosing technology for improved patient outcomes. Their flagship product, the EndoTool Glucose Management System, offers personalized and predictive insulin dosing across the healthcare enterprise, helping to achieve blood glucose control in a shorter time frame for medically complex patients. With proven, patented algorithms, Monarch's software models, predicts, and adapts dosing recommendations to each patient's individual response to insulin, ensuring more precise and safer therapy.
Hospitals using the EndoTool Glucose Management System have reported better patient outcomes, including reduced hypoglycemia, shorter ICU stays, and improved nursing satisfaction. The software is particularly effective in managing hyperglycemia while avoiding hypoglycemia, making it a valuable tool for inpatient glycemic management. Monarch Medical Technologies also provides clinical support and training to ensure the successful implementation and use of their software in healthcare facilities.
Generated from the website